Mexico vs Qatar: Cause of death, by non-communicable diseases, ages 5-14, female
Mexico
57.6%
in 2021
Qatar
57.4%
in 2021
Mexico rank
42nd
Qatar rank
43rd
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Mexico
- Qatar
How they compare
Mexico currently reports 57.6% against 57.4% in Qatar, a difference of 0.2%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Mexico ahead.
Mexico ranks 42nd and Qatar ranks 43rd of 184 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Qatar in 1.
Head to head by decade
| Decade | Mexico | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.6% | 42.4% | 11.1% | Mexico |
| 2010s | 59.6% | 55.1% | 4.5% | Mexico |
| 2020s | 58.0% | 58.0% | 0.0% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Mexico or Qatar?
- Mexico, at 57.6% against 57.4% in Qatar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Mexico and Qatar?
- 0.2%, with Mexico ahead.
- How many years of comparable data are there for Mexico and Qatar?
- 6 years are reported by both, from 2000 to 2021.
- How do Mexico and Qatar rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Mexico ranks 42nd and Qatar ranks 43rd of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.